News | August 13, 2025
Senores Pharmaceuticals acquires ANDAs from Teva Pharmaceuticals USA
The acquired ANDAs represent a market opportunity of about US$ 38 million in the USA
The acquired ANDAs represent a market opportunity of about US$ 38 million in the USA
Subscribe To Our Newsletter & Stay Updated